Newcells Biotech Ltd Revenue and Competitors

Newcastle,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Newcells Biotech Ltd's estimated annual revenue is currently $8.7M per year.(i)
  • Newcells Biotech Ltd's estimated revenue per employee is $155,000

Employee Data

  • Newcells Biotech Ltd has 56 Employees.(i)
  • Newcells Biotech Ltd grew their employee count by 10% last year.

Newcells Biotech Ltd's People

NameTitleEmail/Phone
1
CEO and Co-founderReveal Email/Phone
2
Director OperationsReveal Email/Phone
3
Chief Commercial OfficerReveal Email/Phone
4
Associate Director, iPSC Technology and Head RetinaReveal Email/Phone
5
Chief Innovation OfficerReveal Email/Phone
6
Finance DirectorReveal Email/Phone
7
Chief Scientific Officer and Co-founderReveal Email/Phone
8
Programme managerReveal Email/Phone
9
Production ManagerReveal Email/Phone
10
Office ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Newcells Biotech Ltd?

Newcells Biotech is based at The Biosphere, a purpose built complex for science-based businesses located on The Helix science campus in Newcastle upon Tyne, UK The company was founded in 2014 as a spin out biotechnology company from Newcastle University. The company is founded on the technology and expertise of one of the UK's leading centres for stem cell biology and located alongside one of the largest research-intensive medical university and hospital complexes in the UK. NEW THINKING Human induced pluripotent stem cell (hiPSC) lines are fast becoming instrumental in advances in disease modelling, drug development and drug toxicity. By delivering the “best in biology” human tissue samples and converting these lines into specific cell types, we can significantly improve the unpredictable and costly global drug discovery process. NEW APPROACHES Using our hiPSC and cell biology technology, we create differentiated cells and incorporate them into novel pre-clinical assays covering both human and other key species. NEW OPPORTUNITIES We have the expertise to collaborate with multidisciplinary teams in industry and academia. We are experts in developing cells of the retina, kidney, immune system and skin – making not just simple models, but complex miniature organs to mimic in-vivo human physiology. NEW DISCOVERIES Working with ethically sourced patient samples we can build in-vitro models of diseases to accelerate exploration of targets and new chemical entities.

keywords:N/A

N/A

Total Funding

56

Number of Employees

$8.7M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Newcells Biotech Ltd News

2022-04-17 - Reprogramming a new type of T cell to go after cancers with ...

Without this molecule, these new cells can last much longer than the usual T ... in cord blood mean only a limited number of treatments can be delivered.

2022-04-06 - Hope for stroke? Protein could limit damage by shielding parts ...

The researchers did caution that their work is limited by a small ... Without this molecule, these new cells can last much longer than the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.6M58-6%N/A
#2
$17.2M59-3%N/A
#3
$14.8M617%N/A
#4
$14M620%N/A
#5
$9.1M627%N/A